Investment Rating - The industry investment rating is "Recommended," indicating an expected increase in the industry index by more than 5% over the next 3-6 months compared to the benchmark index [21]. Core Insights - The insurance index rose by 1.03%, outperforming the market by 0.15 percentage points, with notable individual stock performances such as Xinhua (+5.94%) and Taiping (+5.64%) [2]. - China Ping An plans to issue HKD 11.765 billion in convertible bonds, with an initial conversion price of HKD 55.02 per share, aimed at supporting business development and capital needs [3][4]. - As of Q1 2025, Ping An's solvency ratios were 225% for comprehensive solvency and 189% for core solvency, indicating a strong capital position [5]. Summary by Sections Market Performance - The insurance sector showed a mixed performance with individual stocks varying significantly, where Xinhua and Taiping led the gains while Sunshine and Zhong An faced declines [2]. - The 10-year government bond yield was 1.65%, down by 2 basis points from the previous week [2]. Company Developments - China Taiping announced a new private equity fund with a target size of RMB 50 billion, focusing on state-owned enterprise reforms [3]. - Ping An Asset Management received regulatory approval to establish a private fund management company, targeting a first-phase fund size of RMB 30 billion [3]. Financial Metrics - As of June 3, 2025, the closing price of Ping An's H shares was HKD 46.45, with the proposed convertible bond's conversion price exceeding this by HKD 18.45, reflecting confidence in future stock price growth [5]. - The new business value (NBV) for Ping An increased by 35% year-on-year, with significant growth expected from the bancassurance channel [5]. Investment Recommendations - The report suggests a cautious outlook for the short term due to performance pressures but anticipates a recovery in the medium to long term as the industry adapts to interest rate changes and improves operational quality [5]. - Current price-to-earnings (PE) and price-to-book (PB) ratios for key companies are provided, with Ping An rated at 1.04 PB and a strong buy recommendation [10].

Core Viewpoint - The long-term investment pilot program for insurance funds is progressing, with several insurance companies launching new private equity funds to enhance capital market participation and optimize asset allocation [1][2][5]. Group 1: Investment Fund Developments - China Pacific Insurance has launched the Tai Bao Zhi Yuan No. 1 private equity fund with a target size of 20 billion yuan, marking it as one of the second batch of long-term investment pilot funds [1][2]. - The total approved and proposed pilot scale for the long-term investment program has reached 222 billion yuan across three batches [2]. - Other insurance companies, including China Life and New China Life, have also received approval for new funds, with China Life and New China Life establishing the Hong Hu Fund Phase II with a size of 20 billion yuan [2][3]. Group 2: Stock Investment Growth - As of the end of Q1 2025, the stock investment balance for life insurance companies reached 2.65 trillion yuan, an increase of 377.5 billion yuan from the end of 2024, representing 8.43% of their total investment [4]. - Property insurance companies reported a stock investment balance of 171.9 billion yuan, up 11.8 billion yuan from the end of 2024, accounting for 7.56% of their total investment [4]. - Insurance companies have been actively increasing their positions in high-dividend and technology innovation stocks, with a notable rise in equity investments [4]. Group 3: Long-term Performance Assessment - The shift towards long-term performance assessment mechanisms is expected to enhance the investment enthusiasm of insurance funds, allowing for a greater focus on equity investments [5][6]. - Many insurance institutions are optimizing their assessment mechanisms to emphasize long-term performance, which is anticipated to support the stable operation of capital markets [5][6]. - Insurance companies have conducted extensive research on over 1,300 A-share listed companies, focusing on sectors such as electronics, pharmaceuticals, and machinery [6].